Advertisement
Immatics N.V.

Immatics N.V. (IMTX) Stock Overview

Explore Immatics N.V.’s financial performance, market position, analyst ratings, and future outlook.

IMTXNASDAQ
HealthcareBiotechnology
$9.09
$0.34(3.61%)
U.S. Market opens in 4h 7m
Advertisement

Immatics N.V. (IMTX)

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-4.97
EPS (TTM)$-1.97
ROE-0.45%
Fundamental Analysis

AI Price Forecasts

1 Month$12.13
3 Months$15.04
1 Year Target$7.27

IMTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Immatics N.V. (IMTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.06, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.97 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.61%
5-Day Change
2.71%
1-Month Change
-16.38%
3-Month Change
-7.34%
6-Month Change
-9.91%
Year-to-Date (YTD) Change
-13.43%
1-Year Change
49.02%
3-Year Change
-28.54%
5-Year Change
-23.03%
All-Time (Max) Change
-5.31%

Contact Information

49 7071 5397 0
Paul-Ehrlich-Strasse 15, Tübingen, NaN, 72076

Company Facts

5,540 Employees
IPO DateDec 12, 2018
CountryDE
Actively Trading

Frequently Asked Questions